Pfizer (PFE) Receives a Hold from Credit Suisse


Credit Suisse analyst Lorenzo Biasio resumed coverage with a Hold rating on Pfizer (PFE) on July 12 and set a price target of $47. The company’s shares closed on Friday at $42.40.

According to TipRanks.com, Biasio is a 3-star analyst with an average return of 3.2% and a 56.7% success rate. Biasio covers the Healthcare sector, focusing on stocks such as Clovis Oncology, Merck & Company, and Thermo Fisher.

Currently, the analyst consensus on Pfizer is a Moderate Buy with an average price target of $46.83.

See today’s analyst top recommended stocks >>

Pfizer’s market cap is currently $235.6B and has a P/E ratio of 21.74. The company has a Price to Book ratio of 4.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts